Skip to main content
. Author manuscript; available in PMC: 2016 Jun 3.
Published in final edited form as: Neuron. 2015 Jun 3;86(5):1228–1239. doi: 10.1016/j.neuron.2015.04.025

Figure 2. Trial 2 recruits TGFβr-II, but not TrkB signaling, for late phase MAPK activation.

Figure 2

(A1) Trial 1 (0:00) is delivered in the presence of ASW, and drug is applied 10 mins prior to Trial 2 (0:45). SN somata are collected 1 hr post-training (1:45). (A2) Blocking TrkB signaling during Trial 2 does not disrupt late phase MAPK activation. (A3) Blocking TGFβr-II signaling during Trial 2 significantly disrupts late phase MAPK activation. *p<0.05, **p<0.01; n=6–9.